ZURICH/FRANKFURT/LONDON/CHICAGO (May 27): International drug regulators have said the benefits of using Covid-19 vaccines developed by Johnson & Johnson and AstraZeneca outweigh risks as they investigate reports of extremely rare, but potentially fatal blood clots.